All News

If your patient is unable to get pregnant because her partner has cystic fibrosis or congenital bilateral absence of the vas deference, assisted reproductive technology offers a solution. But these disorders have genetic implications that you need to keep in mind when advising such couples.

Here's an update on when and how to use tetanus, HBV, influenza, and other vaccines during pregnancy.

Impact of multifetal pregnancy reduction; review of history of the clinical procedure and discussion of dramatic decrease in loss and prematurity rates.

Urinary incontinence is the involuntary loss of urine to the degree that is socially and hygienically unacceptable to the patient. The amount of leakage, which varies from a few drops to a large gush, usually increases with age.

skin diseases

We must work toward proper balance in the type and number of professionals providing care for patients.

awards

Research pipeline

This infection presents with subtle symptoms and can cause extensive bone destruction.

CME article - exploring other possibilities of infertility

in vitro fertilization

News Updates

News Updates

The symptoms of this infection lack sensitivity and specificity. Once a diagnosis is made, aggressive use of antibiotics and prompt delivery are the mainstays of treatment.

Breastfeeding is an area of medicine in which many obstetrician-gynecologists do not have a lot of clinical training. In this interview, we will learn how an expert in breastfeeding responds to the various clinical concerns and questions that patients bring to her. As a certified lactation consultant, Dr. Friedmann has spent considerable thought, time, and effort in ensuring the implementation and success of breastfeeding.

Results of the HERS, ERA, and WHI trials suggest a conservative approach to use of HRT in women with evidence of CHD. Dose and duration of therapy may be key to the risk-benefit equation.

Ob/gyns have long known that women are disproportionately affected by many autoimmune diseases. Now, new findings about the cellular and molecular activities of the immune system are beginning to explain the causes of these conditions. The next goal: immunologically based treatments.